Plant substances as anti-HIV agents selected according to their putative mechanism of action

被引:68
作者
Cos, P
Maes, L
Vanden Berghe, D
Hermans, N
Pieters, L
Vlietinck, A
机构
[1] Univ Antwerp, Dept Pharmaceut Sci, Lab Pharmacognosy, B-2610 Antwerp, Belgium
[2] Univ Antwerp, Lab Pharmaceut Microbiol, B-2610 Antwerp, Belgium
来源
JOURNAL OF NATURAL PRODUCTS | 2004年 / 67卷 / 02期
关键词
D O I
10.1021/np034016p
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Despite the continuous advances made in antiretroviral combination therapy, AIDS has become the leading cause of death in Africa and the fourth worldwide. Today, many research groups are exploring the biodiversity of the plant kingdom to find new and better anti-HIV drugs with novel mechanisms of action. In this review, plant substances showing a promising anti-HIV activity are discussed according to the viral targets with which they interact. Most of these compounds, however, interfere with early steps in the HIV replication, such as the virus entry steps and the viral enzymes reverse transcriptase and integrase, whereas until now almost no plant compounds have been found to interact with the many other viral targets. Since some plant substances are known to modulate several cellular factors, such as NF-kappa B and TNF-alpha, which are also involved in the replication of HIV, their role as potential anti-HIV products is also discussed. In conclusion, several plant-derived antiviral agents are good candidates to be further studied for their potential in the systemic therapy and/or prophylaxis of HIV infections, most probably in combination with other anti-HIV drugs.
引用
收藏
页码:284 / 293
页数:10
相关论文
共 133 条
[61]   Structure-activity relationships: Analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication [J].
King, PJ ;
Ma, GX ;
Miao, WF ;
Jia, Q ;
McDougall, BR ;
Reinecke, MG ;
Cornell, C ;
Kuan, J ;
Kim, TR ;
Robinson, WE .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (03) :497-509
[62]   Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase [J].
King, PJ ;
Robinson, WE .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8420-8424
[63]   Pharmacognosy in the 21st century [J].
Kinghorn, AD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (02) :135-148
[64]   Baicalin, an inhibitor of HIV-1 production in vitro [J].
Kitamura, K ;
Honda, M ;
Yoshizaki, H ;
Yamamoto, S ;
Nakane, H ;
Fukushima, M ;
Ono, K ;
Tokunaga, T .
ANTIVIRAL RESEARCH, 1998, 37 (02) :131-140
[65]  
KONDO Y, 1992, INT J IMMUNOPHARMACO, V14, P1181
[66]   Effects of prostratin on T-cell activation and human immunodeficiency virus latency [J].
Korin, YD ;
Brooks, DG ;
Brown, S ;
Korotzer, A ;
Zack, JA .
JOURNAL OF VIROLOGY, 2002, 76 (16) :8118-8123
[67]   Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART [J].
Kulkosky, J ;
Culnan, DM ;
Roman, J ;
Dornadula, G ;
Schnell, M ;
Boyd, MR ;
Pomerantz, RJ .
BLOOD, 2001, 98 (10) :3006-3015
[68]   Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region [J].
Labrosse, B ;
Treboute, C ;
Alizon, M .
JOURNAL OF VIROLOGY, 2000, 74 (05) :2142-2150
[69]   INHIBITION OF THE INTEGRASE OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 BY ANTI-HIV PLANT-PROTEINS MAP30 AND GAP31 [J].
LEEHUANG, S ;
HUANG, PL ;
HUANG, PL ;
BOURINBAIAR, AS ;
CHEN, HC ;
KUNG, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8818-8822
[70]   Chicoric acid analogues as HIV-1 integrase inhibitors [J].
Lin, ZW ;
Neamati, N ;
Zhao, H ;
Kiryu, Y ;
Turpin, JA ;
Aberham, C ;
Strebel, K ;
Kohn, K ;
Witvrouw, M ;
Pannecouque, C ;
Debyser, Z ;
De Clercq, E ;
Rice, WG ;
Pommier, Y ;
Burke, TR .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) :1401-1414